FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to urologic diagnostics and is intended for evaluation of prognosis of unilateral or bilateral stone formation development. Laboratory test of patient's urine is performed, by results PHU, MGU, R% and CH CAOX are obtained and linear classification discriminant functions are calculated by the following formulae: F1=-2076.27+22.89* PHU-9784.25* MGU+41.33* R%-2.76* CH CAOX, F2=-2068.17+23.82* PHU-9952.00* MGU+41.20* R%-2.98* CH CAOX, where: F1 - first classification discriminant function corresponds to group of patients with unilateral affection of kidneys, F2 - second discriminant function corresponds to group of patients with bilateral affection; PHU - pH of urine; MGU is concentration of urine magnesium, mole/l; R% is relative tubular reabsorption, %; CH CAOX is degree of urine saturation with calcium oxalate. After that obtained values of the first and second discriminant functions are compared, function whose value turns out to be higher, points to patient's belonging to corresponding group of patients.
EFFECT: method ensures increase of accuracy of unilateral or bilateral nephrolithiasis development.
1 dwg, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR UROLITHIASIS TREATMENT BY PERCUTANEOUS NEPHROLITHOTRIPSY | 2016 |
|
RU2633594C1 |
METHOD FOR PREDICTION OF COMPLICATIONS FOLLOWING CALCANEAL BONE OSTEOSYNTHESIS | 2018 |
|
RU2692952C1 |
METHOD FOR PREDICTION OF FAVORABLE OUTCOME IN PATIENTS WITH THERMAL INJURY FOR CHOOSING THERAPEUTIC APPROACH (VERSIONS) | 2023 |
|
RU2825062C1 |
METHOD OF ASSESSING THE RISK OF KIDNEY TUMOR MALIGNANCY | 2022 |
|
RU2804234C1 |
METABOLIC CORRECTION METHOD IN PATIENTS WITH PROTEIN-ENERGY INSUFFICIENCY (PEI) | 2019 |
|
RU2714315C1 |
METHOD OF TREATING MENTAL AND NEURAL DISORDERS | 2009 |
|
RU2413524C1 |
NEW ENZYMES AND CRISPR SYSTEMS | 2016 |
|
RU2777988C2 |
Authors
Dates
2010-08-20—Published
2009-05-22—Filed